As cell therapy rapidly progresses, tumor infiltrating lymphocyte (TIL) therapies are playing a significant role in shaping the field. What milestones ena...

In this webinar, we’ll discuss our journey in becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand. During the journey...

Learn more about the latest addition to our family of single use chromatography systems and how this will enable you to better purify small volumes in a GM...

In the early clinical development stage of autologous cell therapy manufacture, labor costs often dominate the overall cost of goods sold. However, as manu...

As a major supplier for cell and gene therapy manufacturers, Cytiva continuously strives to advance and accelerate new therapeutics by bringing innovative ...

Enriching mononuclear cells (MNCs) by removing other cell types and contaminants is a critical step in CAR T cell therapy production. But do you know why, ...

Manual cell expansion: variable and prone to errors. Especially when multiple operators are involved. One solution? Automation, which can improve the repro...

In this webinar, we’ll discuss the importance of process development optimization, and some of the key considerations such as: choosing a partner for outso...

New data and insights from the UK’s Advanced Therapy Treatment Centres program The Advanced Therapy Treatment Centres (ATTC) network program— coordinated b...

Adeno-associated virus (AAV) is the most common vector for gene therapy, yet there’s much room to improve production, purification, and analytics. Here we ...